# Sildenafil For Meniere's Disease

> **NCT00145483** · PHASE4 · COMPLETED · sponsor: **Pfizer's Upjohn has merged with Mylan to form Viatris Inc.** · enrollment: 163 (actual)

## Conditions studied

- Meniere's Disease

## Interventions

- **DRUG:** Sildenafil

## Key facts

- **NCT ID:** NCT00145483
- **Lead sponsor:** Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06-18
- **Primary completion:** 2006-11-08
- **Final completion:** 2006-11-08
- **Target enrollment:** 163 (ACTUAL)
- **Last updated:** 2021-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00145483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00145483, "Sildenafil For Meniere's Disease". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00145483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*